CD19 and acute lymphoblastic leukemia: A common finding, regardless of subtype, was that expression of antigens commonly associated with B‐cell precursor (BCP)‐ALL (CD34, CD10, CD19) or T‐ALL (CD4, CD7) was not a prerequisite for disease‐propagating ability in vivo.